DAVENPORT & Co LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$23,000
-4.2%
22,0000.0%0.00%
Q2 2022$24,000
+84.6%
22,000
+83.3%
0.00%
Q1 2022$13,000
+30.0%
12,0000.0%0.00%
Q4 2021$10,000
-79.2%
12,000
-66.7%
0.00%
Q3 2021$48,000
+108.7%
36,000
+200.0%
0.00%
Q2 2021$23,000
-57.4%
12,0000.0%0.00%
-100.0%
Q1 2021$54,00012,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders